Abstract
Aim
To analyze the drinking habits of individuals who overdosed on over‐the‐counter (OTC) drugs, such as cough suppressants, antitussives, antipyretic analgesics, and combination cold medications, in Japan.
Methods
This cross‐sectional study analyzed data collected from 2881 participants through a national survey conducted in Japan in 2023. Through a self‐administered questionnaire, the participants were categorized into OTC (overdosed OTC drugs in the past year) and control (did not overdose OTC drugs) groups. Variables related to drinking habits, social background, smoking habits, use of other medications, such as analgesics, tranquilizers, controlled drugs, and products containing high concentrations of caffeine, and perception of OTC drugs were compared between the two groups. Additionally, we matched the participants in the OTC (n = 25) and control (n = 100) groups by sex and age in a 1:4 ratio to assess these variables. Multivariate analyses were performed to examine how these factors are associated with drinking habits in individuals with OTC drug overdose.
Results
OTC drug overdose was prevalent among teenagers and those in their 50s, and was associated with habitual binge drinking and consumption of energy drinks. Those overdosing on OTC drugs obtained them mostly from drugstores and pharmacies.
Conclusion
This is the first study to show a relationship between drinking habits and OTC drug overdose. An understanding of the characteristics of drinking habits in those who overdose on OTC drugs can help reduce fatal health risks in this population.
Keywords: energy drinks, illegal drugs, misuse, smoking, suicide
Table 2 shows the results of the multivariate logistic regression analyses before and after matching. Before matching, the model included variables that were significantly different: sex, age group, starting to smoke underage, habitual binge drinking, and habitual drinking of energy drinks. After matching, the model included habitual binge drinking and habitual drinking of energy drinks. Habitual alcohol consumption was excluded from the model before matching due to multicollinearity. The multivariable logistic regression analysis before matching revealed that over‐the‐counter (OTC) misuse was associated with the 10–19 and 50–59 years age groups compared to the 40–49 years age group (odds ratio [OR] 13.9, 95% confidence interval [CI] 1.2–310.5 and OR 14.1, 95% CI 2.8–258.5, respectively). OTC misuse was also linked to habitual binge drinking (OR 5.8, 95% CI 1.1–33.4) and habitual energy drink consumption (OR 23.8, 95% CI 3.4–476.4) in the multivariable logistic regression analysis after matching, similar to the results before matching.

INTRODUCTION
Globally, the number of people overdosing on over‐the‐counter (OTC) drugs, such as cough suppressants, antitussives, antipyretic analgesics, and general cold medicines, is increasing. 1 , 2 , 3 , 4 , 5 , 6 These medications contain psychoactive substances such as codeine, 7 dextromethorphan, 8 , 9 diphenhydramine, 10 ephedrine, 11 and pseudoephedrine. 12 These drugs are often misused by overdosing for non‐therapeutic purposes, mostly because OTC drugs are easily accessible and lack strict penalties, unlike controlled drugs. Overdosing OTC drugs is defined as the ingestion of large quantities of medicines containing psychoactive substances, such as cold or cough medicines, in a single instance, exceeding the recommended dosage, not for therapeutic purposes (e.g., relieving cold or cough symptoms) to change sensations or emotions. An overdose of OTC drugs can result in toxic or fatal blood levels, causing severe health problems or death. 3 , 13 For example, an overdose of OTC drugs containing acetaminophen can cause liver damage, 14 and an overdose of drugs containing codeine or dextromethorphan can lead to poisoning. 2 , 3 , 15 , 16 There are reports of people committing suicide by overdosing on OTC drugs. 17 , 18 , 19 , 20 , 21
The risks associated with OTC drug overdosing are further increased by alcohol consumption. 22 , 23 , 24 Postmortem examination of individuals who died from OTC drug overdoses, especially those who committed suicide, often show the presence of alcohol in their bodies. 25 , 26 Alcohol consumption along with an OTC drug overdose accelerates the absorption of the drug's active ingredients, leading to a rapid increase in its blood levels, providing a faster euphoric experience, but also increasing the risk of poisoning, which can be fatal. 27 Therefore, even if the OTC drugs are within the recommended therapeutic doses, 28 , 29 concomitant drinking alcohol should not be allowed due to increased fatal health risks.
Fatal health risks associated with OTC drug overdoses are well known. However, the characteristics of drinking habits in people who overdose on OTC drugs are not well understood. While previous studies have primarily focused on demographic characteristics, such as the age and sex of those who overdose on OTC drugs, they did not investigate the drinking habits of these individuals. 1 , 30 , 31 , 32 , 33 , 34 , 35 , 36 These studies found a higher proportion of women and younger individuals with mental disorders overdosing on OTC drugs. 1 , 30 , 31 , 33 , 34 , 36 Many patients who repeatedly overdose on these drugs develop dependence and experience severe withdrawal symptoms similar to opioid addiction, making self‐control difficult. 32 In Japan, the number of patients with OTC drug use disorders in psychiatric hospitals and emergency cases related to OTC drug overdose has been increasing. 30 , 33 , 34 , 36 To reduce the health risks and fatal outcomes, it is crucial to understand the characteristics of drinking habits in people who overdose on OTC drugs. Additionally, many factors have been reported to be associated with alcohol consumption. Among them, smoking and the use of medicines, controlled drugs, and products containing high concentrations of caffeine are known to affect drug metabolism. Therefore, when combined with alcohol consumption, these factors may potentially cause adverse health effects in individuals who overdose on OTC drugs.
This study mainly aimed to analyze the drinking habits of individuals who overdose on OTC drugs. Additionally, we examined the effects of smoking, and the consumption of controlled drugs and high caffeine‐containing products on OTC drug overdosing. These factors are known to be associated with drinking habits and negatively affect drug metabolism. Data on these factors were collected from a 2023 national survey in Japan. 35 We compared the people who overdosed on OTC drugs with those who did not. Additionally, we examined the sources of the OTC drugs used to overdose by those who overdosed on OTC drugs.
METHODS
Design
This cross‐sectional study used a self‐administered questionnaire and focused on individuals who had overdosed (taken more than the prescribed dose at a time) on OTC drugs containing psychoactive substances, such as cough medicines, cold medicines, and antipyretic analgesics, for no therapeutic purposes (e.g., relieving cold or cough symptoms), but to alter sensations or emotions. Data were collected from the Nationwide General Population Survey on Drugs, 35 a national survey conducted in 2023. The study period was from October 16 to December 22, 2023.
Participant enrolment
Participants included 5000 individuals aged 15–64 years selected from 250 locations across Japan using a stratified two‐stage random sampling method. 35 Japan's prefectures were divided into 11 districts, which were further divided into 65 extractive unit areas (blocks) based on city size (Table S1). City size was classified based on the population recorded in the Basic Resident Register on January 1, 2022. The number of survey cities in each block was determined to avoid bias, with 13–23 participants sampled from each city proportionally distributed according to the population density.
In the first phase, cities were randomly selected using a random number table, ensuring equal sampling intervals by dividing the population aged 15–64 years in each block by the number of cities surveyed. The order of the municipalities followed that of the 2020 census.
In the second phase, participants were randomly selected from each survey city using the Basic Resident Register. The sampling interval was calculated by dividing the population aged 15–64 years in each survey city by the number of cities sampled within each block. This method ensured a nationally representative sample by minimizing regional and population density biases.
The nationwide general population survey
Survey documents (study description, questionnaire form, return envelope, and Internet response guide) were mailed to 5000 participants. Participants responded using either a paper questionnaire or an Internet survey. Consent was confirmed by completing the questionnaire or checking the “I agree” box on the online consent form. Paper respondents mailed the completed questionnaires in the provided envelope. The Internet Response Guide included a login ID, password, response procedure, QR code, and URL for the survey. Participants could respond via computers, smartphones, or tablets and submit their responses once all questions were answered.
Ethical considerations
The study protocol was reviewed and approved by the Ethics Committee of the National Center of Neurology and Psychiatry in Japan (A2023‐031). The survey did not require informed consent. Instead, an opt‐out approach was used. Participants were informed about the survey through a public notice approved by the Ethics Committee and posted on the website. This notice guaranteed the right to refuse participation and withdraw from the survey at any time, even after submitting the completed questionnaires. The withdrawal procedure was detailed in the public notice, survey descriptions, and questionnaire forms. These documents stated: “Responses are anonymous,” “Participation is voluntary,” and “There are no disadvantages for not participating.” This study adhered to the principles of the Declaration of Helsinki.
Participant selection
We excluded 1974/5000 participants surveyed nationwide in the 2023 General Population Survey on Drug Use. The proportion of the number of participants at each location to the total study population (n = 5000) was 0.08%–0.24% and was comparable to the proportion of the number of respondents at each location to the total respondents in this study (n = 3026).
As our study focused on individuals engaged in OTC drug overdose, we excluded 53 participants with incomplete information regarding the overdose and 92 who did not complete all the survey questions. Finally, we included 2881 participants in the study. Based on their responses to a self‐administered questionnaire on OTC drug overdose within the past year, the participants were categorized into OTC (participants who overdosed on OTC drugs, n = 25) and control (participants who did not overdose on OTC drugs, n = 2856) groups as shown in Figure 1.
Figure 1.

Flowchart of participant selection and the matching process. Through a self‐administered questionnaire, the participants were asked, “In the past year, have you overdosed on OTC cough medicines, cold medicines, or fever reducers for abusive (not therapeutic) purposes? Abusive use was defined as the use of more than a set amount or number of times to get high or change mood.” Those who answered “yes” were classified into the OTC drug overdose group. Those who answered “no” were classified into the control group. OTC, over‐the‐counter.
Variables
The OTC and control groups were compared for several variables, including sex, age (mean), age group (in 10‐year increments), employment status, educational level, drinking habits, smoking habits, use of high caffeine‐containing products, medicines, and controlled drugs, and the perception of OTC overdose. These variables were selected based on previous reports that focused on patients with OTC drug use disorders in psychiatric hospitals and emergency cases. 30 , 33 , 34 , 36
In addition to the average age, we included the number of people in each age group as a variable because while the average age shows a central tendency, it does not capture the spread or bias of the age distribution. A comparison of the number of individuals in each age group helped identify potential biases. We also categorized employment status into self‐employed, full‐time, part‐time, student, other occupations, and unemployed.
The drinking habits were categorized into (a) started drinking before 20 years of age, (b) drinking for the last month, (c) habitual drinking for the last year, and (d) habitual binge drinking for the last year. Based on the National Health and Nutrition Survey, habitual drinking was defined as drinking alcohol for more than 3 days every week for a month, while habitual binge drinking was drinking more than approximately 1400 ml of alcohol with an alcohol content of 5% or more on a single occasion, more than 3 days a week for a month. 37 In this study, we categorized drinking habit variables in several ways because different patterns of drinking habits (such as the age of initiation, frequency of drinking, and quantity consumed) are associated with different health risks and behaviors. Each of these patterns may have a different impact on OTC drug overdose. This approach aimed to evaluate how each drinking habit specifically influences OTC drug overdose.
The smoking habits were categorized as started smoking before 20 years of age (underage) and heavy smoking. Based on the National Health and Nutrition Survey, heavy smoking was defined as smoking for more than 20 days per month. 37
The status of consumption of high‐caffeine products, such as energy drinks and caffeine tablets, was added as a new variable. Overdosing with caffeine‐containing OTC drugs can lead to caffeine poisoning if consumed simultaneously with high‐caffeine products. Habitual intake of these products was defined as consumption three or more times a week.
Considering that people who overdose on OTC drugs tend to have mental disorders, we added the habitual use of analgesics and tranquilizers as another variable. People with chronic pain are more likely to have mental disorders. 38 , 39 , 40 The habitual use of analgesics and tranquilizers in combination with OTC drug overdosing was added as a variable because of its adverse effects. Habitual use of these medications was defined as their use at least three times per week in the past year.
We included variables related to the use of controlled drugs such as marijuana, methamphetamine, inhalants, MDMA, cocaine, heroin, new psychotropic substances, and lysergic acid diethylamide in the past year. In addition, thoughts on the acceptability of controlled drug use, specifically marijuana, which is the most commonly used controlled drug in Japan, were also added as a variable. 35 , 41 , 42 , 43 This variable was added because we believe that people overdosing on OTC drugs might have different ideas about using them than those who did not misuse them.
Finally, we added variables to assess participants’ knowledge of the health risks associated with OTC drug overdose. These included awareness that overdosing on OTC drugs can lead to addiction and that taking large doses can cause death. 44 , 45
Statistical analyses
We compared the characteristics of the OTC and control groups using Student's t‐tests for continuous variables and chi‐square tests for categorical variables. The participants in the OTC and control groups were exact‐matched by age and sex in a 1:4 ratio to control for differences that could distort the relationship between OTC overdose and other variables, including drinking habits and smoking habits.
Using multivariable logistic regression analyses, we quantified the impact of each variable and calculated its odds ratios. We checked the variance inflation factors to examine multicollinearity, and factors <10 indicated no multicollinearity. All statistical analyses were performed using R version 4.2.3 (R Foundation for Statistical Computing, Vienna, Austria) (https://www.r-project.org/). Statistical significance was set at P < 0.05. A multivariate regression analysis was performed before matching, and the 40–49 age group was used as the reference. Since a previous study showed a higher proportion of OTC drug use disorder in teens and those in their 20s compared to those in their 30s and 40s, 36 we evaluated the relationship with each age group using 40s as the reference.
For the OTC group, we further investigated the sources of OTC drugs used for overdose, classifying them as pharmacies and drugstores, the Internet, transfer from an acquaintance or family member, regular home medicine, other sources, or unknown sources.
RESULTS
The sex, age, and age group trends of the participants are shown in Table S2. Before matching, the mean (standard deviation) ages of the OTC and control groups were 46.8 (14.3) and 43.4 (13.7) years, respectively (P = 0.221). There were no sex‐based differences between the two groups (44.0% vs. 50.6%, P = 0.649) (Table 1). However, significant differences were seen in age before matching (P = 0.015). Compared to the control group, the OTC group had higher proportions of people aged 15–19 (8.0% vs. 6.5%) and 50–59 (60.0% vs. 28.1%). After matching, the variables significantly associated with OTC overdose were habitual binge drinking and habitual energy drink consumption.
Table 1.
Comparison of the characteristics between the OTC and control groups before and after matching.
| Before matching | After matching | |||||
|---|---|---|---|---|---|---|
| OTC group (n = 25) | Control group (n = 2856) | P value | OTC group (n = 25) | Control group (n = 100) | P value | |
| Variables used for matching | ||||||
| Sex, female, number (%) | 11 (44.0) | 1,445 (50.6) | 0.649 | 11 (44.0) | 44 (44.0) | 1.000 |
| Age in years (mean (SD)) | 46.8 (14.3) | 43.4 (13.7) | 0.221 | 46.8 (14.3) | 46.8 (14.1) | 1.000 |
| Age group (years) | 0.015 | 1.000 | ||||
| 15–19 | 2 (8.0) | 185 (6.5) | 2 (8.0) | 8 (8.0) | ||
| 20–29 | 2 (8.0) | 364 (12.7) | 2 (8.0) | 8 (8.0) | ||
| 30–39 | 3 (12.0) | 498 (17.4) | 3 (12.0) | 12 (12.0) | ||
| 40–49 | 1 (4.0) | 650 (22.8) | 1 (4.0) | 4 (4.0) | ||
| 50–59 | 15 (60.0) | 802 (28.1) | 15 (60.0) | 60 (60.0) | ||
| 60–64 | 2 (8.0) | 357 (12.5) | 2 (8.0) | 8 (8.0) | ||
| Variables not used for matching | ||||||
| Employment status | ||||||
| Unemployed | 1 (4.0) | 144 (5.0) | 1.000 | 1 (4.0) | 4 (4.0) | 1.000 |
| Self‐employed | 3 (12.0) | 218 (7.6) | 0.660 | 3 (12.0) | 5 (5.0) | 0.411 |
| Full‐time | 11 (44.0) | 1506 (52.7) | 0.503 | 11 (44.0) | 59 (59.0) | 0.260 |
| Part‐time | 5 (20.0) | 377 (13.2) | 0.483 | 5 (20.0) | 12 (12.0) | 0.473 |
| Student | 3 (12.0) | 254 (8.9) | 0.849 | 3 (12.0) | 9 (9.0) | 0.939 |
| Other work | 2 (8.0) | 357 (12.5) | 0.708 | 2 (8.0) | 11 (11.0) | 0.942 |
| High‐school graduate | 12 (48.0) | 1818 (63.7) | 0.158 | 12 (48.0) | 63 (63.0) | 0.254 |
| Drinking alcohol status | ||||||
| Beginning, underage | 16 (64.0) | 1557 (54.5) | 0.455 | 16 (64.0) | 68 (68.0) | 0.886 |
| Drinking in the past month | 18 (72.0) | 1722 (60.3) | 0.324 | 18 (72.0) | 60 (60.0) | 0.380 |
| Habitual drinking | 11 (44.0) | 542 (19.0) | 0.004 | 11 (44.0) | 27 (27.0) | 0.159 |
| Habitual binge drinking | 4 (16.0) | 74 (2.6) | <0.001 | 4 (16.0) | 3 (3.0) | 0.041 |
| Smoking status | ||||||
| Beginning, underage | 14 (56.0) | 894 (31.3) | 0.015 | 14 (56.0) | 37 (37.0) | 0.133 |
| Heavy smoker | 5 (20.0) | 545 (19.1) | 1.000 | 5 (20.0) | 33 (33.0) | 0.307 |
| Status of taking the products, including high levels of caffeine | ||||||
| Habitual drinking of energy drinks | 5 (20.0) | 115 (4.0) | 0.001 | 5 (20.0) | 1 (1.0) | 0.001 |
| Habitual use of caffeine tablets | 1 (4.0) | 74 (2.6) | 1.000 | 1 (4.0) | 1 (1.0) | 0.859 |
| Status of using the medications for therapeutic purposes | ||||||
| Habitual use of analgesics | 1 (4.0) | 103 (3.6) | 1.000 | 1 (4.0) | 3 (3.0) | 1.000 |
| Habitual use of tranquilizers | 2 (8.0) | 114 (4.0) | 0.614 | 2 (8.0) | 3 (3.0) | 0.568 |
| Have used controlled drugs | 0 (0.0) | 90 (3.2) | 0.746 | 0 (0.0) | 6 (6.0) | 0.464 |
| Perception about using controlled drugs | ||||||
| Marijuana should not be used | 24 (96.0) | 2769 (97.0) | 1.000 | 24 (96.0) | 96 (96.0) | 1.000 |
| Knowing that abusing OTC can lead to addiction | 6 (24.0) | 628 (22.0) | 1.000 | 6 (24.0) | 23 (23.0) | 1.000 |
| Knowing that taking large doses of OTC at once can cause death | 3 (12.0) | 369 (12.9) | 1.000 | 3 (12.0) | 14 (14.0) | 1.000 |
Abbreviations: OTC, over‐the‐counter; SD, standard deviation.
Note: Data are presented as n (%) unless otherwise indicated. Drinking, beginning underage: Started drinking before the age of 20 years. Drank in the past month: Drank alcohol within the past month. Habitual drinking: Drank alcohol more than three times every week. Habitual binge drinking: Engaged in binge drinking, defined as consuming more than approximately 1400 ml of alcohol with an alcohol content of 5% or more on a single occasion. Smoking, beginning underage: Started smoking before the age of 20. Heavy smoking: Smoking more than 20 days per month. Habitual drinking of energy drinks: Drank energy drinks more than 20 days per month. Habitual use of caffeine tablets: Took caffeine tablets for over 20 days per month. Habitual use of analgesics: Took analgesics more than three times every week. Habitual use of tranquilizers: Took tranquilizers more than three times every week. We considered P < 0.05 to indicate statistical significance.
Table 2 shows the results of the multivariate logistic regression analyses before and after matching. Before matching, the model included variables that were significantly different: sex, age group, starting to smoke underage, habitual binge drinking, and habitual drinking of energy drinks. After matching, the model included habitual binge drinking and habitual drinking of energy drinks. Habitual alcohol consumption was excluded from the model before matching due to multicollinearity. The multivariable logistic regression analysis before matching revealed that OTC overdose was associated with the 15–19 and 50–59 years age groups compared to the 40–49 years age group (odds ratio [OR] 13.9, 95% confidence interval [CI] 1.2–310.5 and OR 14.1, 95% CI 2.8–258.5, respectively). OTC overdose was also linked to habitual binge drinking (OR 5.8, 95% CI 1.1–33.4) and habitual energy drink consumption (OR 23.8, 95% CI 3.4–476.4) in the multivariable logistic regression analysis after matching, similar to the results before matching.
Table 2.
Multivariable conditional logistic regression analysis.
| Before matching | After matching | |||||
|---|---|---|---|---|---|---|
| Odds ratio | 95% CI | P value | Odds ratio | 95% CI | P value | |
| Sex, female | 1.3 | 0.5–3.1 | 0.555 | |||
| Age group (years) | ||||||
| 15–19 | 13.9 | 1.2–310.5 | 0.037 | |||
| 20–29 | 5.3 | 0.5–117.1 | 0.175 | |||
| 30–39 | 4.6 | 0.6–93.2 | 0.184 | |||
| 40–49 | Reference | ‐ | ‐ | |||
| 50–59 | 14.1 | 2.8–258.5 | 0.011 | |||
| 60–64 | 4.3 | 0.4–95.6 | 0.209 | |||
| Beginning of smoking, underage | 2.6 | 1.0–6.5 | 0.050 | |||
| Habitual binge‐drinking alcohol | 5.9 | 1.4–15.7 | 0.002 | 5.8 | 1.1–33.4 | 0.037 |
| Habitual consumption of energy drinks | 7.8 | 2.4–21.7 | <0.001 | 23.8 | 3.4–476.4 | 0.005 |
Abbreviation: CI, confidence interval.
Note: Habitual binge drinking alcohol: Engaged in binge drinking, defined as consuming more than approximately 1400 ml of alcohol with an alcohol content of 5% or more on a single occasion. Beginning of smoking, underage: Started smoking before the age of 20. Habitual drinking of energy drinks: Participants drank energy drinks more than 20 days per month. Statistical significance was set at P < 0.05. The Akaike's information criteria for the model before and after matching were 270.81 and 115.11, respectively. The variables that were significantly associated with OTC overdose before matching were habitual binge drinking, smoking, and habitual energy drink consumption. These variables were entered into a logistic regression model. The variables that were significantly associated with OTC overdose after matching were habitual alcohol binge drinking and habitual energy drink consumption, therefore these two variables were entered into a logistic regression analysis model.
The sources of OTC drugs used for overdose were physical shops, such as pharmacies and drugstores (36%), regular medicines at home (16%), the Internet (4%), and unknown sources (56%).
DISCUSSION
To the best of our knowledge, this study is the first to use the National General Population Survey to compare the characteristics of drinking habits of people who overdosed on OTC drugs with those who did not. This study found that OTC drug overdose was particularly prevalent among teenagers and middle‐aged adults, and was associated with habitual binge drinking. Additionally, the habitual use of high‐caffeine products such as energy drinks has also been linked to OTC drug overdose. One‐third of those who overdosed on OTC drugs obtained them from pharmacies or drugstores.
Age groups
We found that people who overdosed on OTC drugs were predominantly teenagers, which is consistent with previous studies showing that many psychiatric patients addicted to OTC drugs are teenagers. 46 This study also found that people in their 50s frequently overdosed on OTC drugs. As with teenagers, individuals in their 50s who overdose on OTC drugs may also suffer from mental illnesses, such as depression. In addition, in teenagers, overdosing is associated with loneliness, stress, and disrupted habits such as poor sleep and skipping breakfast. 1 , 47 , 48 Therefore, it is likely that middle‐aged and older adults who overdose on OTC drugs may also be facing stress and loneliness.
This study found no significant differences in the sex of participants who overdosed on OTC drugs. This is in contrast to previous surveys that showed more women overdosing on OTC drugs. 36 , 49 This discrepancy could be due to our study's broader age range (15–64 years) and general population survey, while previous studies focused on high school students 49 and psychiatric hospital patients, 36 leading to different participant backgrounds. Since this study only included participants aged 15 and above, the exclusion of those under 15, who were included in previous studies, might have also impacted the results. Additionally, the sample size for young women was limited, which may have made it difficult to detect significant sex‐based differences in risk. Based on this, future research using a larger dataset, including a more targeted sample of young women, is needed to examine sex‐based differences in risk more thoroughly.
Binge‐drinking alcohol
Our results show that individuals who overdosed on OTC drugs tended to engage in heavy drinking habits. Previous studies have suggested that those who overdose on OTC drugs in combination with alcohol are at a significant risk of fatal health issues. 22 , 23 , 24 , 28 , 50 Additionally, there have been reports of individuals intentionally consuming alcohol to enhance the effects of OTC drugs when attempting suicide. 29 , 51 , 52 , 53 , 54 People who overdose on OTC drugs and engage in heavy drinking might be trying to cope with mental distress and stress. Another reason could be to commit suicide. Drinking alcohol, self‐harming, and OTC drug overdoses are temporary methods to relieve stress and mental pain. 55 Moreover, a previous study suggested a close relationship between substance use, including OTC drug overdose, binge alcohol consumption, and suicidal ideation, suggesting that these substances alleviate feelings of loneliness or hopelessness. 56 Additionally, some people binge on drinking alcohol and overdose on OTC drugs as alternatives to self‐harm or to alleviate suicidal thoughts. 19 , 53 Although these agents offer temporary relief, they ultimately do more harm. 50
The age groups associated with OTC drug overdose in this study (teenagers and those in their 50s) were more likely to be engaged in habitual binge drinking, suggesting that they may also be at a very high risk of fatal outcomes, including suicide. The age groups with the highest suicide rates in Japan are 15–24 and 40–59 years, 57 which aligns with the findings of our study. Individuals who overdose on OTC drugs experience mental health issues such as depression and anxiety, which can lead to suicidal ideation and create a vicious cycle of OTC drug overdose. Based on these findings, psychological support, including suicide prevention measures, may be necessary not only for young people but also for middle‐aged individuals who overdose on OTC drugs. However, this study did not evaluate the mental state of the participants, therefore further research is needed to investigate the relationship between OTC drug overdose, drinking habits, and suicide.
Consumption of energy drinks
Consistent with previous studies focusing on controlled and prescription drugs, 58 , 59 , 60 , 61 we found a significant association between OTC drug overdose and energy drink consumption. Caffeine from energy drinks combined with an overdose of OTC drugs, including caffeine, can lead to coronary artery spasms, thrombosis, cardiac arrhythmias, and sudden cardiac death. 59 It is therefore crucial to warn individuals who overdose on OTC drugs of the fatal health risks associated with these substances.
OTC drug overdosing is often combined with the consumption of energy drinks to counter intoxication by drinking or to enhance the drug's effects. A significant relationship between drinking habits and the habitual consumption of energy drinks has been previously reported. 60 , 61 , 62 In addition, combining caffeine and alcohol reduces the perceived intoxication, increases stimulation, and heightens the desire to consume more alcohol, thereby increasing the associated risks. 63 Mixing energy drinks with alcohol is linked to a higher risk of binge drinking, impaired driving, risky sexual behavior, and alcohol dependence than consuming alcohol alone. 62 , 63 , 64 , 65 We found that OTC drug overdose was significantly associated with the consumption of energy drinks but not caffeine tablets. The finding might be that energy drinks are readily available at convenience stores and vending machines, whereas caffeine tablets are sold only at pharmacies for limited hours.
To the best of our knowledge, this is the first study to report a direct relationship between energy drinks and OTC drug overdose. While several studies have previously suggested a link between energy drinks and the use of illicit drugs or prescription medications, 58 , 66 , 67 these analyses typically adjusted for factors such as sex, age, and race, without specifically considering the impact of alcohol consumption. In contrast, we adjusted for both alcohol and energy drink consumption, and the results suggest a potential association between energy drinks and OTC drug overdose. However, it is important to acknowledge that other unknown variables may not have been fully accounted for, and the possibility remains that factors other than alcohol may still be influencing this relationship.
Sources of OTC drugs used for overdose
We found that people who overdose on OTC drugs are more likely to obtain them from physical stores, such as drugstores and pharmacies, rather than online. Our results align with previous studies showing that consumers prefer physical stores for OTC drug purchases, often due to face‐to‐face consultations with pharmacists. 66 , 67 , 68 , 69 Most consumers in countries such as Sweden 68 (76%) and Japan 67 (89%) still prefer buying OTC drugs from physical stores to online. While the one‐third rate in our study is lower than the result of previous studies, it is still significantly higher than the 4% of misusers who purchase online.
However, the reasons to choose physical shops over online in general consumers may differ from people who overdose on OTC drugs. People who overdose on OTC drugs may choose physical stores for quick access to drugs, which is harder to achieve with online purchases.
As online purchasing increases among convenience‐seeking consumers, 67 and with some OTC drugs legally obtainable online in Japan, there might be a growing need for policy discussions on how interventions for OTC drug overdose should be implemented in physical stores and online purchases. Our findings might suggest that in‐store interventions involving pharmacists as gatekeepers could play a critical role in preventing OTC drug overdose. Some countries, including Japan, are already working to establish pharmacists in this preventative role. 70 , 71 , 72 , 73
Limitations
This study has some limitations. First, using a self‐administered questionnaire for the general population requires keeping the questions simple and easy to understand, and omitting detailed questions about the ingredients and product names of the OTC drugs. Therefore, we could not investigate the characteristics of individuals who overdosed on OTC drugs based on different ingredients or products. Second, the data were collected through self‐reporting, which may have introduced reporting bias. Third, the mental health status of the participants was not assessed, which may have affected the OTC drug overdose. Fourth, the frequency and amount of overdose of OTC drugs were not evaluated, which could have influenced the findings of the study.
The primary objective of this study was to evaluate potential associations between OTC drug overdosing and drinking habits and to explore how other factors, such as smoking, consumption of high‐caffeine products, and use of medicine and controlled drugs, might influence this relationship. Since there are several common causes for drinking and OTC drug overdose, it is difficult for a cross‐sectional study like this one to clarify the causal relationship between the two. However, the findings from this study could serve as a foundation for future longitudinal studies to further investigate causality.
CONCLUSION
Our results showed that the overdose of OTC drugs was more common among those in their teens and 50s and was significantly associated with habitual binge drinking. OTC drug overdosing was also associated with the consumption of high‐caffeine products, such as energy drinks. Finally, overdosers mostly obtain OTC drugs from drugstores and pharmacies. We believe our findings can help in reducing the health risks and fatal outcomes of OTC drug overdose by addressing the associated factors and regulating the availability of these drugs to populations who are likely to overdose on them.
AUTHOR CONTRIBUTIONS
T.S. and S.M. designed the preliminary experiments. S.I. and S.M. recruited participants and collected data. T.S., S.I., and S.M. established the database of research participants. T.S. obtained funding. S.M. designed the study, performed statistical analyses, and wrote the manuscript. T.S., S.I., and T.M. supervised the study design and wrote the manuscript. S.M. wrote the initial draft of the manuscript. All authors revised and contributed to the final version of the manuscript. All authors have read and approved the final manuscript for publication.
CONFLICT OF INTEREST STATEMENT
The authors declare no conflict of interest.
ETHICS APPROVAL STATEMENT
The study protocol was reviewed and approved by the Ethics Committee of the National Center of Neurology and Psychiatry of Japan (A2023‐031) and conformed to the provisions of the Declaration of Helsinki.
PATIENT CONSENT STATEMENT
Informed consent was not obtained for the survey. Instead, an opt‐out approach was adopted. The participants could withdraw from the research at any time during the study. The information on how to cancel their participation was posted on the website of the Ethics Committee of the institution concerned.
CLINICAL TRIAL REGISTRATION
N/A.
Supporting information
SUPPORTING INFORMATION TABLE S1 Number of participants and survey cities in each block of Japan.
SUPPORTING INFORMATION TABLE S2 The sex, age, and age group tendencies in the entire cohort.
ACKNOWLEDGMENTS
The authors thank Mr. Matsumura Takahiro of Wakara Co. (Tokyo, Japan) for contributing to the statistical procedures used in this study. This study was supported by a Health Labor Research Grant from the Ministry of Health, Labor, and Welfare, Research on Pharmaceutical and Medical Regulatory Science (Principal Investigator, T. Shimane; Grant number, 202324038A).
Mizuno S, Inoura S, Matsumoto T, Shimane T. Characteristics of the drinking habits of people who overdose over‐the‐counter drugs: Insights from a nationwide Japanese survey. Psychiatry Clin Neurosci Rep. 2024;3:e70027. 10.1002/pcn5.70027
DATA AVAILABILITY STATEMENT
In order to protect the confidentiality of study participants, the data are unavailable.
REFERENCES
- 1. Levine DA. Pharming’: the abuse of prescription and over‐the‐counter drugs in teens. Curr Opin Pediatr. 2007;19:270–274. [DOI] [PubMed] [Google Scholar]
- 2. Schifano F, Chiappini S, Miuli A, Mosca A, Santovito MC, Corkery JM, et al. Focus on over‐the‐counter drugs’ misuse: a systematic review on antihistamines, cough medicines, and decongestants. Front Psychiatry. 2021;12:657397. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Gunn VL, Taha SH, Liebelt EL, Serwint JR. Toxicity of over‐the‐counter cough and cold medications. Pediatrics. 2001;108:e52. [DOI] [PubMed] [Google Scholar]
- 4. Cooper RJ. I can't be an addict. I am.’ Over‐the‐counter medicine abuse: a qualitative study. BMJ Open. 2013;3:e002913. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Cooper RJ. Over‐the‐counter medicine abuse—a review of the literature. J Subst Use. 2013;18:82–107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Cooper R. Surveillance and uncertainty: community pharmacy responses to over the counter medicine abuse: surveillance and uncertainty. Health Soc Care Community. 2013;21:254–262. [DOI] [PubMed] [Google Scholar]
- 7. Orriols L, Gaillard J, Lapeyre‐Mestre M, Roussin A. Evaluation of abuse and dependence on drugs used for self‐medication: a pharmacoepidemiological pilot study based on community pharmacies in France. Drug Saf. 2009;32:859–873. [DOI] [PubMed] [Google Scholar]
- 8. Roberge RJ, Hirani KH, Rowland PL, Berkeley R, Krenzelok EP. Dextromethorphan‐ and pseudoephedrine‐induced agitated psychosis and ataxia: case report. J Emerg Med. 1999;17:285–288. [DOI] [PubMed] [Google Scholar]
- 9. Stanciu CN, Penders TM. Mania after misuse of dextromethorphan: a case report and brief review of “Robotripping”. J Addict Med. 2015;9:159–160. [DOI] [PubMed] [Google Scholar]
- 10. Thapliyal N, Patel H, Karpoormath R, Goyal RN, Patel R. A categorical review on electroanalytical determination of non‐narcotic over‐the‐counter abused antitussive drugs. Talanta. 2015;142:157–163. [DOI] [PubMed] [Google Scholar]
- 11. Tseng YL, Hsu HR, Kuo FH, Shieh MH, Chang CF. Ephedrines in over‐the‐counter cold medicines and urine specimens collected during sport competitions. J Anal Toxicol. 2003;27:359–365. [DOI] [PubMed] [Google Scholar]
- 12. Alevizos B. Dependence and chronic psychosis with D‐nor‐pseudoephedrine. Eur Psychiatry. 2003;18:423–425. [DOI] [PubMed] [Google Scholar]
- 13. Blechman KM, Karch SB, Stephens BG. Demographic, pathologic, and toxicological profiles of 127 decedents testing positive for ephedrine alkaloids. Forensic Sci Int. 2004;139:61–69. [DOI] [PubMed] [Google Scholar]
- 14. McGill MR, Sharpe MR, Williams CD, Taha M, Curry SC, Jaeschke H. The mechanism underlying acetaminophen‐induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation. J Clin Invest. 2012;122:1574–1583. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Lo MY, Ong MW, Lin JG, Sun WZ. Codeine consumption from over‐the‐counter anti‐cough syrup in Taiwan: a useful indicator for opioid abuse. Acta Anaesthesiologica Taiwanica. 2015;53:135–138. [DOI] [PubMed] [Google Scholar]
- 16. Ontiveros S, Cantrell L. Fatal cold medication poisoning in an adolescent. Am J Emerg Med. 2022;52:269.e1–2. [DOI] [PubMed] [Google Scholar]
- 17. Mikhail A, Tanoli O, Légaré G, Dubé PA, Habel Y, Lesage A, et al. Over‐the‐counter drugs and other substances used in attempted suicide presented to emergency departments in Montreal, Canada. Crisis. 2019;40:166–175. [DOI] [PubMed] [Google Scholar]
- 18. Shoib S, Patel V, Khan S, Armiya'u AY, Saeed F, Swed S, et al. Over‐the‐counter drug use in suicidal/self‐harm behavior: scoping review. Health Sci Rep. 2022;5:e662. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Lo A, Shalansky S, Leung M, Hollander Y, Raboud J. Patient characteristics associated with nonprescription drug use in intentional overdose. Can J Psychiatry. 2003;48:232–236. [DOI] [PubMed] [Google Scholar]
- 20. Sinyor M, Howlett A, Cheung AH, Schaffer A. Substances used in completed suicide by overdose in Toronto: an observational study of coroner's data. Can J Psychiatry. 2012;57:184–191. [DOI] [PubMed] [Google Scholar]
- 21. Huott MA, Storrow AB. A survey of adolescents’ knowledge regarding toxicity of over‐the‐counter medications. Acad Emerg Med. 1997;4:214–218. [DOI] [PubMed] [Google Scholar]
- 22. Hickman M, Lingford‐Hughes A, Bailey C, Macleod J, Nutt D, Henderson G. Does alcohol increase the risk of overdose death: the need for a translational approach. Addiction. 2008;103:1060–1062. [DOI] [PubMed] [Google Scholar]
- 23. Mahdi I, Tomedi LE, Gerrard CY, Lathrop S, Landen M. Excessive alcohol use and drug overdose deaths, New Mexico, 2015‐2016. Drug Alcohol Depend. 2020;215:108175. [DOI] [PubMed] [Google Scholar]
- 24. White AM, Hingson RW, Pan I, yi H. Hospitalizations for alcohol and drug overdoses in young adults ages 18–24 in the United States, 1999‐2008: results from the Nationwide Inpatient Sample. J Stud Alcohol Drugs. 2011;72:774–786. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Jones AW, Holmgren A, Ahlner J. Toxicology findings in suicides: concentrations of ethanol and other drugs in femoral blood in victims of hanging and poisoning in relation to age and gender of the deceased. J Forensic Leg Med. 2013;20:842–847. [DOI] [PubMed] [Google Scholar]
- 26. Holmgren A, Jones AW. Demographics of suicide victims in Sweden in relation to their blood‐alcohol concentration and the circumstances and manner of death. Forensic Sci Int. 2010;198:17–22. [DOI] [PubMed] [Google Scholar]
- 27. Linnoila M, Mattila MJ, Kitchell BS. Drug interactions with alcohol. Drugs. 1979;18:299–311. [DOI] [PubMed] [Google Scholar]
- 28. Cousins G, Galvin R, Flood M, Kennedy MC, Motterlini N, Henman MC, et al. Potential for alcohol and drug interactions in older adults: evidence from the Irish longitudinal study on ageing. BMC Geriatr. 2014;14:57. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Dart R. The use and effect of analgesics in patients who regularly drink alcohol. Am J Manag Care. 2001;7:S597–S601. [PubMed] [Google Scholar]
- 30. Irene S, Yasmin S, ExadaktylosAristomenis K, Manuel H, LiechtiMatthias E, Evangelia L. Emergency department presentations related to overdose of prescription and over‐the‐counter drugs in Switzerland: time trends, sex and age distribution. Swiss Med Wkly. 2019;149:w20056. [DOI] [PubMed] [Google Scholar]
- 31. Benotsch EG, Koester S, Martin AM, Cejka A, Luckman D, Jeffers AJ. Intentional misuse of over‐the‐counter medications, mental health, and polysubstance use in young adults. J Community Health. 2014;39:688–695. [DOI] [PubMed] [Google Scholar]
- 32. Ballantyne JC, Sullivan MD, Koob GF. Refractory dependence on opioid analgesics. Pain. 2019;160:2655–2660. [DOI] [PubMed] [Google Scholar]
- 33. Hashimoto T, Kaneda Y, Ozaki A, Hori A, Tsuchiya T. Eleven‐year trend of drug and chemical substance overdose at a local emergency hospital in Japan. Cureus. 2022;14:e32475. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Yasuda M, Kobayashi T. Suicide attempts by drug overdose at Jichi Medical University Hospital emergency centre: a study of patient characteristics and quantity of drug overdose. Asian J Psychiatry. 2019;41:34–37. [DOI] [PubMed] [Google Scholar]
- 35. Shimane T, Mizuno S, Inoura S, Chu D. Research on the actual situation of drug overdose and dependence and support for the social reintegration of drug‐dependent persons 2023 Summary report. Tokyo: 2024. Available from: https://www.ncnp.go.jp/nimh/yakubutsu/report/pdf/J_NGPS_2023.pdf [Google Scholar]
- 36. Matsumoto T, Usami T, Funada D, Okita K, Makino E, Yamamoto T. Survey of drug‐related psychiatric disorders in psychiatric facilities nationwide. 2022. Available from: https://www.ncnp.go.jp/nimh/yakubutsu/report/pdf/J_NMHS_2022.pdf
- 37. Office of Nutrition Health Service Division Health Service Bureau Ministry of Health Labour and Welfare . The National Health and Nutrition Survey in Japan, 2019. Tokyo: 2021. Available from: https://www.mhlw.go.jp/content/001066903.pdf
- 38. Manchikanti L, Giordano J, Boswell MV, Fellows B, Manchukonda R, Pampati V. Psychological factors as predictors of opioid overdose and illicit drug use in chronic pain patients. J Opioid Manag. 2007;3:89–100. [DOI] [PubMed] [Google Scholar]
- 39. Sullivan MD, Edlund MJ, Steffick D, Unützer J. Regular use of prescribed opioids: association with common psychiatric disorders. Pain. 2005;119:95–103. [DOI] [PubMed] [Google Scholar]
- 40. Hooten WM. Chronic pain and mental health disorders. Mayo Clin Proc. 2016;91:955–970. [DOI] [PubMed] [Google Scholar]
- 41. Shimane T, Inoura S, Chu D, Wada K. Research on the actual situation of drug overdose and dependence and support for the social reintegration of drug‐dependent persons 2019 Summary report. Tokyo: 2020. Available from: https://www.ncnp.go.jp/nimh/yakubutsu/report/pdf/J_NGPS_2019.pdf
- 42. Shimane T, Chu D, Wada K. Research on the actual situation of drug overdose and dependence and support for the social reintegration of drug‐dependent persons 2017 Summary report. Tokyo: 2018. Available from: https://www.ncnp.go.jp/nimh/yakubutsu/report/pdf/J_NGPS_2017.pdf
- 43. Shimane T, Inoura S, Yamaguchi Y, Chu D, Wada K. Research on the actual situation of drug overdose and dependence and support for the social reintegration of drug‐dependent persons 2021 Summary report. Tokyo: 2022. Available from: https://www.ncnp.go.jp/nimh/yakubutsu/report/pdf/J_NGPS_2021.pdf [Google Scholar]
- 44. Romanelli F, Smith KM. Dextromethorphan abuse: clinical effects and management. J Am Pharm Assoc. 2009;49:e20–e27. [DOI] [PubMed] [Google Scholar]
- 45. Boyer E, Burns J. Antitussives and substance overdose. Subst Overdose Rehabil. 2013;4:75–82. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Williams JF, Kokotailo PK. Abuse of proprietary (over‐the‐counter) drugs. Adolesc Med Clin. 2006;17:733–750. [DOI] [PubMed] [Google Scholar]
- 47. Steinman KJ. High school students’ misuse of over‐the‐counter drugs: a population‐based study in an urban county. J Adolesc Health. 2006;38:445–447. [DOI] [PubMed] [Google Scholar]
- 48. Stickley A, Koyanagi A, Koposov R, Schwab‐Stone M, Ruchkin V. Loneliness and health risk behaviours among Russian and US adolescents: a cross‐sectional study. BMC Public Health. 2014;14:366. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Shimane T. National high school student survey on drug use and lives (2021). 2021.
- 50. Flensborg‐Madsen T, Knop J, Mortensen EL, Becker U, Sher L, Grønbæk M. Alcohol use disorders increase the risk of completed suicide—irrespective of other psychiatric disorders. A longitudinal cohort study. Psychiatry Res. 2009;167:123–130. [DOI] [PubMed] [Google Scholar]
- 51. Magne‐Ingvar U, Öjehagen A, Träskman‐Bendz L. Suicide attempters with and without reported overconsumption of alcohol and tranqdllizers. Nord J Psychiatry. 1997;51:415–421. [Google Scholar]
- 52. Sher L, Oquendo MA, Richardson‐Vejlgaard R, Makhija NM, Posner K, Mann JJ, et al. Effect of acute alcohol use on the lethality of suicide attempts in patients with mood disorders. J Psychiatr Res. 2009;43:901–905. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Borges G, Loera CR. Alcohol and drug use in suicidal behaviour. Curr Opin Psychiatry. 2010;23:195–204. [DOI] [PubMed] [Google Scholar]
- 54. MA Al‐Sharqi, Sherra SK, AL‐Habeeb AA, Qureshi AN. Suicidal and self‐injurious behavior among patients with alcohol and drug overdose. Subst. Overdose Rehabil. 2012;3:91–99. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Robinson J, Sareen J, Cox BJ, Bolton J. Self‐medication of anxiety disorders with alcohol and drugs: results from a nationally representative sample. J Anxiety Disord. 2009;23:38–45. [DOI] [PubMed] [Google Scholar]
- 56. Zullig KJ, Divin AL. The association between non‐medical prescription drug use, depressive symptoms, and suicidality among college students. Addict Behav. 2012;37:890–899. [DOI] [PubMed] [Google Scholar]
- 57. Office of Suicide Prevention Ministry of Health Labour and Welfare . Number of suicides based on National Police Agency suicide statistics. Tokyo Japan: 2024. Available from: https://www.mhlw.go.jp/content/001197856.pdf
- 58. Arria AM, Caldeira KM, Kasperski SJ, O'Grady KE, Vincent KB, Griffiths RR, et al. Increased alcohol consumption, nonmedical prescription drug use, and illicit drug use are associated with energy drink consumption among college students. J Addict Med. 2010;4:74–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Hladun O, Papaseit E, Martín S, Barriocanal AM, Poyatos L, Farré M, et al. Interaction of energy drinks with prescription medication and drugs of abuse. Pharmaceutics. 2021;13:1532. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Trapp GSA, Allen KL, O'Sullivan T, Robinson M, Jacoby P, Oddy WH. Energy drink consumption among young Australian adults: associations with alcohol and illicit drug use. Drug Alcohol Depend. 2014;134:30–37. [DOI] [PubMed] [Google Scholar]
- 61. Arria AM, Caldeira KM, Kasperski SJ, Vincent KB, Griffiths RR, O'Grady KE. Energy drink consumption and increased risk for alcohol dependence. Alcohol Clin Experiment Res. 2011;35:365–375. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Kristjansson AL, Mann MJ, Sigfusdottir ID, James JE. Mode of daily caffeine consumption among adolescents and the practice of mixing alcohol with energy drinks: relationships to drunkenness. J Stud Alcohol Drugs. 2015;76:397–405. [DOI] [PubMed] [Google Scholar]
- 63. Marczinski CA, Fillmore MT. Energy drinks mixed with alcohol: what are the risks? Nutr Res. 2014;72:98–107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64. Terry‐McElrath YM, O'Malley PM, Johnston LD. Energy drinks, soft drinks, and substance use among United States secondary school students. J Addict Med. 2014;8:6–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Dillon P, Kelpin S, Kendler K, Thacker L, Dick D, Svikis D. Gender differences in any‐source caffeine and energy drink use and associated adverse health behaviors. J Caffeine Adenosine Res. 2019;9:12–19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66. Leal, WE , Jackson DB. Energy drinks and escalation in drug use severity: an emergent hazard to adolescent health. Prev Med. 2018;111:391–396. [DOI] [PubMed] [Google Scholar]
- 67. Tang G, Izumi K, Izumisawa M, Koyama S. Analysis of Japanese consumers’ attitudes toward the digital transformation of OTC medicine purchase behavior and eHealth literacy: an online survey for digital experience design. Front Digit Heal. 2023;5:1173229. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68. Håkonsen H, Sundell KA, Martinsson J, Hedenrud T. Consumer preferences for over‐the‐counter drug retailers in the reregulated Swedish pharmacy market. Health Policy. 2016;120(3):327–333. [DOI] [PubMed] [Google Scholar]
- 69. Chan V, Tran H. Purchasing over‐the‐counter medicines from Australian pharmacy: what do the pharmacy customers value and expect? Pharm Pract. 2016;14:782. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70. Sansgiry SS, Bhansali AH, Bapat SS, Xu Q. Overdose of over‐the‐counter medicines: a pharmacist's perspective. Integr Pharm Res Pract. 2016;6:1–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71. Offu OF, Visram S, Rathbone AP, Lindsey L. Factors influencing pharmacists’ roles in preventing prescription and over‐the‐counter opioid misuse: a systematic review and narrative synthesis. Int J Pharm Pract. 2024;32:133–145. [DOI] [PubMed] [Google Scholar]
- 72. Baum L, Badejo G, Chaboyer K, Leong C. Pharmacist‐led interventions for the management of medication misuse and abuse: a systematic review. J Am Pharmacist Assoc. 2017;57:297–298. [DOI] [PubMed] [Google Scholar]
- 73. Shimane T. The pharmacist as gatekeeper: combating medication abuse and dependence. Yakugaku Zasshi. 2013;133:617–630. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
SUPPORTING INFORMATION TABLE S1 Number of participants and survey cities in each block of Japan.
SUPPORTING INFORMATION TABLE S2 The sex, age, and age group tendencies in the entire cohort.
Data Availability Statement
In order to protect the confidentiality of study participants, the data are unavailable.
